The Register · A provider

Central Institute for Mental Health (CIMH/ZI Mannheim)

Mannheim, Germany · Germany

Address & contact

https://www.zi-mannheim.de

psychedelic treatment psilocybin therapy psychiatric research clinical trials neuroimaging research

Psychedelic Treatment Quality in Germany: BfArM-authorized compassionate use psilocybin facility since July 2025; member of Leibniz Association; led by Prof. Dr. Gerhard Gründer; conducts EPIsoDE Phase 2b trial; operates on inpatient basis with outpatient follow-up; includes neuroimaging data collection to identify biological markers